Last updated on March 2019

Evaluation of the Efficacy Durability Safety and Tolerability of RP-G28 in Patients With Lactose Intolerance


Brief description of study

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on symptom reduction related to lactose intolerance.

Clinical Study Identifier: NCT03597516

Contact Investigators or Research Sites near you

Start Over

Research Site

Lampasas, TX United States

Research Site

Lincoln, CA United States

Research Site

San Diego, CA United States

Research Site

Gainesville, FL United States

Research Site

Orlando, FL United States

Research Site

Great Neck, NY United States

Research Site

Hartsdale, NY United States

Research Site

Knoxville, TN United States

Research Site

Houston, TX United States

Research Facility

Birmingham, AL United States

Research Site

Panorama City, CA United States

Research Site

Walnut Creek, CA United States

Research Site

Colorado Springs, CO United States

Research Facility

Miami, FL United States

Reseaarch Site

Pompano Beach, FL United States

Research Site

Honolulu, HI United States

Research Site

Marrero, LA United States

Research Site

Oxon Hill, MD United States

Research Site

Wyoming, MI United States

Research Site

Omaha, NE United States

Research Site

Albuquerque, NM United States

Research Site

Dayton, OH United States

Research Site

Fairfax, VA United States

Research Site

Waxahachie, TX United States

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.